Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

Dan Turner

doi:10.1093/ibd/izaa039

Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

Dan Turner^*

^*Corresponding author for this work

Shaare Zedek Medical Center

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	E42
Journal	Inflammatory Bowel Diseases
Volume	26
Issue number	5
DOIs	https://doi.org/10.1093/ibd/izaa039
State	Published - 11 Apr 2020
Externally published	Yes

Funding

Funders
Leona M. and Harry B. Helmsley Charitable Trust

Access to Document

10.1093/ibd/izaa039

Cite this

@article{cf8ffd3b2fba4826834992f755520fdd,

title = "Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al",

author = "Dan Turner",

year = "2020",

month = apr,

day = "11",

doi = "10.1093/ibd/izaa039",

language = "אנגלית",

volume = "26",

pages = "E42",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Antibiotics in Refractory IBD

T2 - Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

AU - Turner, Dan

PY - 2020/4/11

Y1 - 2020/4/11

UR - https://www.scopus.com/pages/publications/85083623226

U2 - 10.1093/ibd/izaa039

DO - 10.1093/ibd/izaa039

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32095806

AN - SCOPUS:85083623226

SN - 1078-0998

VL - 26

SP - E42

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 5

ER -

Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

Funding

Access to Document

Other files and links

Cite this